Grover disease may result from the impairment of keratinocytic cholinergic receptors

Journal of the American Academy of Dermatology

Volumn 66, Issue 2, 2012, Pages 332-333

  Paslin, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; VARENICLINE;

ACANTHOLYSIS; ADULT; BIOPSY; CASE REPORT; CONCENTRATION LOSS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DYSKERATOSIS; HUMAN; HUMAN TISSUE; INSOMNIA; KERATINOCYTE; LETTER; LYMPHOCYTIC INFILTRATION; MALE; NAUSEA; PAPULE; PRIORITY JOURNAL; SMOKING; TRANSIENT ACANTHOLYTIC DERMATOSIS;

EID: 84855823601     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.08.015     Document Type: Article

References (5)

1. J.N. Mehta, and A.G. Martin A case of pemphigus vulgaris improved by cigarette smoking Arch Dermatol 136 2000 15 17 (Pubitemid 30038791)
2. J. Arredondo, V. Nguyen, A. Chernyavsky, M. Shfii, K. Pinkerton, and S. Grando Reciprocal changes in the expressions of nicotinic acetylcholine receptors and the cell cycle and differentiation genes can mediate pathobiologic effects of tobacco products on keratinocytes J Invest Dermatol 117 2001 478 (abstr)
3. H. Rollema, L.K. Chambers, J.W. Coe, J. Glowa, R.S. Hurst, and L.A. Lebel Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacol 52 2007 985 994 (Pubitemid 46227486)
4. J.W. Coe, P.R. Brooks, M.G. Vetelino, M.C. Wirtz, E.P. Arnold, and J. Huang Varenicline: an α4β2 nicotinic receptor partial agonist for smoking cessation J Med Chem 48 2005 3474 3477 (Pubitemid 40664098)
5. K.B. Mihalak, F.I. Carroll, and C.W. Luetje Varenicline is a partial agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors Mol Pharmacol 70 2006 801 805 (Pubitemid 44268437)